Andrea B. Thomas - 20 Jun 2024 Form 4 Insider Report for MEDIFAST INC (MED)

Role
Director
Signature
/s/ Jason L. Groves, attorney-in-fact
Issuer symbol
MED
Transactions as of
20 Jun 2024
Transactions value $
$0
Form type
4
Filing time
24 Jun 2024, 17:50:00 UTC
Previous filing
09 Nov 2023
Next filing
26 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MED Common Stock Award $0 +6,596 +1.05% $0 12,849 20 Jun 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 6,596 restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These awards are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 20, 2025.